Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience.
about
Inhibition of G9a Histone Methyltransferase Converts Bone Marrow Mesenchymal Stem Cells to Cardiac Competent ProgenitorsPharmacological Therapy in the Heart as an Alternative to Cellular Therapy: A Place for the Brain Natriuretic Peptide?In vivo experience with natural scaffolds for myocardial infarction: the times they are a-changin'Cardiac Regenerative Medicine: The Potential of a New Generation of Stem CellsStem cells for the treatment of heart failureElectromechanical Conditioning of Adult Progenitor Cells Improves Recovery of Cardiac Function After Myocardial Infarction.Translational aspects of cardiac cell therapy.Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.Hurdles to clinical translation of human induced pluripotent stem cells2005 Donor Eligibility Requirements: Unintended Consequences for Stem Cell Development.Pluripotent stem cell applications for regenerative medicineThe Universal 3D3 Antibody of Human PODXL Is Pluripotent Cytotoxic, and Identifies a Residual Population After Extended Differentiation of Pluripotent Stem CellsPosition Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.Stem cell death and survival in heart regeneration and repair.Comparative transcriptomic analysis identifies genes differentially expressed in human epicardial progenitors and hiPSC-derived cardiac progenitors.Current Neurogenic and Neuroprotective Strategies to Prevent and Treat Neurodegenerative and Neuropsychiatric Disorders.Current status of pluripotent stem cells: moving the first therapies to the clinic.Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments.Genetic and Epigenetic Regulation of Human Cardiac Reprogramming and Differentiation in Regenerative MedicinePluripotent stem cells progressing to the clinic.Cryopreservation of Human Pluripotent Stem Cell-Derived Cardiomyocytes: Strategies, Challenges, and Future Directions.Fibrin, the preferred scaffold for cell transplantation after myocardial infarction? An old molecule with a new life.Therapeutic angiogenesis: angiogenic growth factors for ischemic heart disease.Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model.Cellular Therapy for Heart Failure.Id genes are essential for early heart formationPreventing Pluripotent Cell Teratoma in Regenerative Medicine Applied to Hematology Disorders.Are we closer to cardiac regeneration?Mesenchymal stem cell therapy: A promising cell-based therapy for treatment of myocardial infarction.Involment of RAS/ERK1/2 signaling and MEF2C in miR-155-3p inhibition-triggered cardiomyocyte differentiation of embryonic stem cell.Human Pluripotent Stem Cell-Derived Cardiac Tissue-like Constructs for Repairing the Infarcted Myocardium.Stem cell therapies for myocardial infarction in clinical trials: bioengineering and biomaterial aspects.Antiarrhythmic effect of growth factor-supplemented cardiac progenitor cells in chronic infarcted heart.Generation of Induced Cardiospheres via Reprogramming of Skin Fibroblasts for Myocardial Regeneration.Comparison of Non-human Primate versus Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Treatment of Myocardial Infarction.Bone Marrow Very Small Embryonic-Like Stem Cells: New Generation of Autologous Cell Therapy Soon Ready for Prime Time?Bone marrow-derived mesenchymal stem cell-loaded fibrin patches act as a reservoir of paracrine factors in chronic myocardial infarction.Is Human-induced Pluripotent Stem Cell the Best Optimal?Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types.[Cell therapies for cardiopathies: the shift of paradigms].
P2860
Q22306435-4FAF4AA6-0F7C-4FB8-9DFA-0F852EA108CAQ26765883-48D3F811-BCBB-4C5F-A18F-601D656015DBQ26775715-5C47ADE7-6B78-42C6-BD2D-78435DA1C855Q28079057-0DF94048-3B7B-4DC9-9676-B63B01B0F387Q28082047-E2DCAAF9-EE0F-4321-8FF9-068FE07E406DQ33722403-7CA4ED6D-2D4F-4C77-8E06-528F16E43B08Q35995055-7B4F666A-0983-40A0-A701-F7684C350E57Q36011869-95426AE5-15BA-4477-B35E-7345CC4EDA7EQ36040255-A1B08D7F-562A-474B-B142-138016B49AE6Q36067846-1B14D80F-23AA-49B5-A7C3-98A0F7F15025Q36255019-B8C95631-4F91-4A95-956E-5A898D4DB16AQ36756141-A14C29E2-B6C4-4B4F-AEB2-EC6A8F322FB3Q37016190-FA17A583-DD7F-4CDA-AFE5-4035C87665DAQ37545373-92AD7190-E11B-475A-BA0B-DAA7A7D034ABQ38440913-802398B2-7A5F-40EF-AABE-804D1E554EECQ38587566-058A0551-158C-4D97-8ACA-4EB4A6306000Q38590664-31CB6061-99F1-449B-BF9A-D0AF0A67985CQ38626782-40FABC16-29A1-4D02-B5CB-C96980417B35Q38657334-01DE1EDD-B444-4C80-9BC3-77AE0BFBB2B5Q38747535-676C0A31-F312-4903-8897-BD7BF39D38F6Q38796118-F8B64516-E66A-477E-943F-6177EF7D8F76Q38802979-DB3DBD1F-CE08-49A8-95FD-CAC0FCF92E35Q38841567-EAD4BBF2-ED1D-4355-BC86-87DEAD532D6EQ38842308-75026956-E7DB-4C1D-81AC-DC2D26997346Q38859871-488BA536-5B95-4790-B700-D2069FF8F5F7Q41590446-0F409405-C464-4943-A3FF-AB6288A8BC52Q41896979-F5DAE44B-C7AC-494A-855F-379DFF8349F1Q42370394-F1C468E6-AA00-422C-963D-453EB8977604Q46374324-FA530A48-559D-4094-9DF3-0B16299E3D5FQ47100264-3BEC7787-DEC4-40D9-A44A-F23F3EB8F6BCQ47377047-8ABB7FC1-58C4-41E4-A57A-F70634E6F6FEQ47719713-21ADC9FE-798B-4284-BAE5-294CC5E2CCF5Q48623367-489BA56B-9862-45B9-B68E-AE7C1707B48EQ48661614-967A35E9-79D0-4049-95F5-9EF159DE5077Q49341169-FE382B26-F6E4-48D0-AA2C-A7F7E22EFDBAQ50946128-609E9457-FF5C-4F62-8010-FE4D89E8613DQ51019182-FC89BC5E-4C81-4697-9169-89E4E7F83BEBQ52631688-8D125F5E-36F1-4B11-8AD9-30D4B2DB0270Q52729630-82A844B3-DA99-457B-8179-7623DEF37485Q53670624-6FD23B2A-8198-4756-B243-67D3848E744C
P2860
Towards a clinical use of human embryonic stem cell-derived cardiac progenitors: a translational experience.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Towards a clinical use of huma ...... s: a translational experience.
@ast
Towards a clinical use of huma ...... s: a translational experience.
@en
Towards a clinical use of huma ...... s: a translational experience.
@nl
type
label
Towards a clinical use of huma ...... s: a translational experience.
@ast
Towards a clinical use of huma ...... s: a translational experience.
@en
Towards a clinical use of huma ...... s: a translational experience.
@nl
prefLabel
Towards a clinical use of huma ...... s: a translational experience.
@ast
Towards a clinical use of huma ...... s: a translational experience.
@en
Towards a clinical use of huma ...... s: a translational experience.
@nl
P2093
P2860
P50
P356
P1476
Towards a clinical use of huma ...... s: a translational experience.
@en
P2093
Jean-Hugues Trouvin
Jean-Roch Fabreguettes
Julia Pouly
Jérôme Larghero
Marie-Cécile Périer
Michel Desnos
Odile Damour
Patrick Bruneval
Philippe Menasché
P2860
P304
P356
10.1093/EURHEARTJ/EHU192
P577
2014-05-16T00:00:00Z